Robin R. Young CFA is a medical industry analyst who has been named one of The Wall Street Journal's "Best on the Street" and among the top-10 analysts in the United States by Institutional Investor. With more than 23 years of industry experience, he is the president and founder of Robin Young Consulting Group and RRY Publications, which publishes industry newsletters and produces the Stem Cell Summit. Earlier in his career, he was instrumental in forming and managing HealthpointCapital's research and private equity practice. In addition, he was a managing director for Stephens Inc., Piper Jaffray & Co. and John G. Kinnard & Co.

$950
early registration
(October/November 2007)

$1,200
pre-conference registration
(December 2007/
January 2008)

$1,500
February 2008 and onsite

Register early.
Space is limited.

If you are a paid subscriber to Orthopedics This Week you can receive a $250 discount.